Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAI oxaliplatin in unresectable liver-only colorectal metastases
NCT05103020Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Nov 2021
- Primary completion
- Mar 2023
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of oxaliplatin in colorectal cancer (CRC), sponsored by Yonsei University. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05103020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05103020.